Infections in hepatitis B cirrhosis patients
Part of Digestive system, Infections clinical trials.
This study looks at the types of germs (bacteria or viruses) that cause infections in people who have cirrhosis from Hepatitis B. The goal is to learn which germs are common, so doctors can better treat or prevent such infections in the future.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 70 years old
- You have tested positive for Hepatitis B for more than 6 months
- You have been diagnosed with cirrhosis (liver scarring) and show signs of liver failure or high blood pressure in the portal vein
- You are currently in the hospital and willing to sign a consent form
- Your cirrhosis is not caused by other liver conditions like fat or alcohol
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at the bacteria in the gut of people with liver cirrhosis to better understand how they relate to the disease. By joining, you help researchers learn more about cirrhosis, which may lead to better care in the future.
This study is looking at the types of infections that can occur in people with severe liver failure (when the liver stops working) who have hepatitis B or E. By identifying these infections, doctors hope to better treat and prevent complications in patients like you.
This study collects a small sample of liver cells to understand how hepatitis B virus behaves in the liver and how the immune system responds. This could help improve future treatments for chronic hepatitis B.
This study looks at how patients with chronic hepatitis B are managed when they visit non-liver clinics. It aims to improve care and may also include a survey about quality of life for those starting treatment.
This study looks at bacterial infections in people with cirrhosis to understand which antibiotics still work. The goal is to improve treatment for future patients with liver disease.
This study looks at the genes of people with chronic hepatitis B (HBV) to find why some people's immune cells (B cells and NK cells) stop working properly. The goal is to discover new ways to treat the disease.
Hear when a new Liver Cirrhosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.